Variables | n (%) |
---|---|
Age (years) | |
 Mean ± SD | 55.85 ± 13.24 |
 Median (IQR) | 55 (46 – 65) |
 Age group | |
  16 – 30 | 12 (2.4) |
  31 – 40 | 54 (10.8) |
  41 – 50 | 131 (26.2) |
  51 – 60 | 137 (27.4) |
  61 – 70 | 112 (22.4) |
 71 – 80 | 39 (7.8) |
   > 80 | 15 (3.0) |
Sex | |
 Female | 254 (50.8) |
 Male | 246 (49.2) |
Educationa | |
 Uneducated | 110 (22.04) |
 Up to higher secondary | 282 (57.51) |
 Graduate | 80 (16.03) |
 Postgraduate | 27 (5.41) |
Employmenta | |
 No job | 131 (26.25) |
 Part time | 212 (42.48) |
 Full time | 111 (22.24) |
 Retired | 45 (9.02) |
Monthly family Income (BDT) | |
 < 5000 | 84 (16.8) |
 5000—25,000 | 296 (59.2) |
 > 25,000 | 120 (24.0) |
Duration of diabetes (years) | |
 Mean ± SD | 11.27 ± 7.86 |
 Median (IQR) | 10 (5 – 15) |
Categories | |
 ≤ 10 | 268 (53.6) |
 11 – 20 | 181 (36.2) |
 > 20 | 51 (10.2) |
Years passed without medication | |
 Mean ± SD | 1.79 ± (3.26) |
 Median (IQR) | 0 (0 – 3) |
 Categories |  |
 None to < 1 | 311 (62.2) |
 1—< 3 | 63 (12.6) |
 3—< 5 | 45 (9.0) |
 ≥ 5 | 81 (16.2) |
Hypoglycemic agents usedb | |
 Metformin | 47 (9.4) |
 Sulfonylureas | 21 (4.2) |
 Alpha glucosidase | 2 (0.4) |
 DPP IV inhibitors | 17 (3.4) |
 Rapid-acting Insulin | 184 (36.8) |
 Intermediate-acting insulin | 140 (28.0) |
 Long-acting insulin | 7 (1.4) |
 Mixed insulin | 109 (21.8) |
Comorbiditiesb | |
 Hypertension | 352 (70.4) |
 Overweight/obesity | 379 (76.0) |
Complicationsb | |
 Microvascular complications | |
  Nephropathy | 145 (29.0) |
  Neuropathy | 108 (21.6) |
  Retinopathy | 51 (10.2) |
 Macrovascular complications | |
  Coronary artery disease | 65 (13.0) |
  Stroke | 26 (5.2) |
  Peripheral artery disease | 21 (4.2) |
  Diabetic foot | 53 (10.6) |
 Acute complication | |
  History of hypoglycemia | 290 (58.0) |
 Number of complications | |
  None | 265 (53.0) |
  One | 115 (23.0) |
  Two | 56 (11.2) |
  Three or more | 64 (12.8) |